Equities analysts forecast that IntriCon Co. (NASDAQ:IIN) will announce earnings per share of $0.16 for the current fiscal quarter, Zacks reports. Two analysts have provided estimates for IntriCon’s earnings. The highest EPS estimate is $0.18 and the lowest is $0.14. IntriCon posted earnings of $0.07 per share during the same quarter last year, which would indicate a positive year-over-year growth rate of 128.6%. The business is expected to announce its next quarterly earnings report on Monday, February 11th.
On average, analysts expect that IntriCon will report full year earnings of $0.72 per share for the current fiscal year, with EPS estimates ranging from $0.70 to $0.74. For the next fiscal year, analysts forecast that the firm will post earnings of $0.93 per share, with EPS estimates ranging from $0.82 to $1.09. Zacks Investment Research’s EPS averages are a mean average based on a survey of sell-side research firms that that provide coverage for IntriCon.
IntriCon (NASDAQ:IIN) last issued its quarterly earnings results on Monday, November 5th. The technology company reported $0.22 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.20 by $0.02. IntriCon had a return on equity of 13.06% and a net margin of 4.82%. The firm had revenue of $30.13 million for the quarter, compared to analyst estimates of $30.23 million.
Several equities analysts have issued reports on IIN shares. TheStreet raised IntriCon from a “c+” rating to a “b” rating in a research note on Friday, August 31st. B. Riley boosted their price target on IntriCon from $62.00 to $73.00 and gave the company a “buy” rating in a research note on Wednesday, August 22nd. Stifel Nicolaus upped their target price on IntriCon from $65.00 to $70.00 and gave the stock a “buy” rating in a research report on Friday, September 21st. ValuEngine lowered IntriCon from a “strong-buy” rating to a “buy” rating in a research report on Friday. Finally, Zacks Investment Research raised IntriCon from a “hold” rating to a “buy” rating and set a $39.00 target price on the stock in a research report on Wednesday, November 14th. One investment analyst has rated the stock with a hold rating and five have issued a buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus price target of $48.50.
Several large investors have recently modified their holdings of the company. Acadian Asset Management LLC raised its position in shares of IntriCon by 3.1% during the third quarter. Acadian Asset Management LLC now owns 56,179 shares of the technology company’s stock worth $3,157,000 after purchasing an additional 1,715 shares during the period. First Mercantile Trust Co. acquired a new position in shares of IntriCon during the third quarter worth approximately $159,000. Bank of New York Mellon Corp raised its position in shares of IntriCon by 17.0% during the third quarter. Bank of New York Mellon Corp now owns 21,512 shares of the technology company’s stock worth $1,209,000 after purchasing an additional 3,131 shares during the period. Navellier & Associates Inc raised its position in shares of IntriCon by 30.9% during the second quarter. Navellier & Associates Inc now owns 15,142 shares of the technology company’s stock worth $610,000 after purchasing an additional 3,577 shares during the period. Finally, CAPROCK Group Inc. acquired a new position in shares of IntriCon during the third quarter worth approximately $251,000. 59.51% of the stock is currently owned by institutional investors.
Shares of IIN opened at $31.09 on Wednesday. IntriCon has a 52-week low of $16.70 and a 52-week high of $76.80. The company has a market capitalization of $286.53 million, a price-to-earnings ratio of 51.81, a price-to-earnings-growth ratio of 3.84 and a beta of 0.95.
IntriCon Company Profile
IntriCon Corporation, together with its subsidiaries, designs, develops, engineers, manufactures, and distributes body-worn devices in the United States, Europe, Asia, and internationally. The company operates in two segments, Body Worn Devices and Hearing Health Direct-To-Consumer. It offers micro-miniature products, microelectronics; micro-mechanical assemblies; high-precision injection-molded plastic components; and assemblies and software solutions for medical bio-telemetry devices, hearing healthcare, and professional audio communication devices markets.
Featured Story: How does inflation affect different investments?
Get a free copy of the Zacks research report on IntriCon (IIN)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for IntriCon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IntriCon and related companies with MarketBeat.com's FREE daily email newsletter.